Insights

Strategic partnerships Vanqua Bio has actively formed collaborations with CHDR and Ardena, signaling openness to co-development and contracted research, which creates a pathway for joint ventures, licensing, or milestone-driven collaborations on CNS programs and GCase/GBA1 targets.

Clinical momentum The company is in early to mid-phase clinical development with VQ-101 and is presenting interim Phase 1b data at major neuroscience conferences, indicating continued funding appetite and a need for CRO support, clinical trial services, and regulatory affairs partnerships.

GCase and genetics Focused on brain-penetrant GCase activation and human genetic insights for neurodegenerative diseases, presenting a selling point for manufacturing, biomarker development, and translational biology services aligned with lysosomal storage disorder pathways.

Regional exposure Key conferences and international venues (World Parkinson’s Congress, GBA1 Meeting, AD/PD) underscore opportunities for global SITE sponsorships, investigator-initiated trials, and access to academic networks for pivotal study sites and patient cohorts.

Scale and funding With revenue in the multi-million range and substantial backing ($130M+), Vanqua Bio is positioned for strategic service partnerships, early-access programs, and technology licensing deals to accelerate discovery tool commercialization and in vitro modeling capabilities.

Similar companies to Vanqua Bio

Vanqua Bio Tech Stack

Vanqua Bio uses 8 technology products and services including WordPress, Shopify, Really Simple Discovery, and more. Explore Vanqua Bio's tech stack below.

  • Content Management System
  • E-commerce
  • Really Simple Discovery
    Miscellaneous
  • Ubuntu
    Operating Systems
  • Yoast SEO
    Search Engines
  • GoDaddy
    Web Hosting
  • Apache
    Web Servers

Media & News

Vanqua Bio's Email Address Formats

Vanqua Bio uses at least 1 email format:
Vanqua Bio Email FormatsExamplePercentage
LastF@vanquabio.comDoeJ@vanquabio.com
100%

Frequently Asked Questions

What is Vanqua Bio's official website and social media links?

Minus sign iconPlus sign icon
Vanqua Bio's official website is vanquabio.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Vanqua Bio generate?

Minus sign iconPlus sign icon
As of November 2026, Vanqua Bio's annual revenue is estimated to be $10M - $25M.

What is Vanqua Bio's SIC code and NAICS code?

Minus sign iconPlus sign icon
Vanqua Bio's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Vanqua Bio have currently?

Minus sign iconPlus sign icon
As of November 2026, Vanqua Bio has approximately 37 employees across 1 continents, including North America. Key team members include Vice President & Corporate Controller: T. D., Director Of Program & Project Management: G. B. and Clinical Program Manager: B. S. Explore Vanqua Bio's employee directory with LeadIQ.

What industry does Vanqua Bio belong to?

Minus sign iconPlus sign icon
Vanqua Bio operates in the Biotechnology Research industry.

What technology does Vanqua Bio use?

Minus sign iconPlus sign icon
Vanqua Bio's tech stack includes WordPress, Shopify, Really Simple Discovery, Ubuntu, Yoast SEO, DigitalOcean Web Hosting, GoDaddy and Apache.

What is Vanqua Bio's email format?

Minus sign iconPlus sign icon
Vanqua Bio's email format typically follows the pattern of LastF@vanquabio.com. Find more Vanqua Bio email formats with LeadIQ.

How much funding has Vanqua Bio raised to date?

Minus sign iconPlus sign icon
As of November 2026, Vanqua Bio has raised $130M in funding. The last funding round occurred on Jul 05, 2024 for $45M.

When was Vanqua Bio founded?

Minus sign iconPlus sign icon
Vanqua Bio was founded in 2019.
Vanqua Bio logo

Vanqua Bio

Biotechnology ResearchIllinois, United States11-50 Employees

Vanqua Bio is a clinical-stage biotechnology company focused on neurodegenerative diseases. Its work centers on leveraging human genetic insights to identify genes associated with the onset or progression of conditions such as Parkinson’s disease, Alzheimer’s disease, ALS, and Gaucher disease, with the aim of developing therapies that slow or halt disease progression. The company uses patient-derived neuronal cells and in vitro disease models to inform its drug-development efforts, seeking to address longstanding neuroscience challenges with a genetically informed approach.
Based in Chicago, Vanqua Bio operates in the biotechnology research sector and collaborates with partners to advance its programs. Its activity includes presenting interim data from early-phase studies and engaging in partnerships to support its phase 1 work, illustrating a focus on translating genetic and cellular insights into potential therapies for neurodegenerative disorders.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2019
Employees
11-50

Section iconFunding & Financials

  • $130M

    Vanqua Bio has raised a total of $130M of funding over 3 rounds. Their latest funding round was raised on Jul 05, 2024 in the amount of $45M as a Venture Round.

  • $10M - $25M

    Vanqua Bio's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.